Anti-obesity effect of phosphatidylinositol on diet-induced obesity in mice

Journal of Agricultural and Food Chemistry

Volumn 58, Issue 21, 2010, Pages 11218-11225

  Shimizu, Kosuke ^a   Ida, Tomoko ^a   Tsutsui, Haruhito ^a   Asai, Tomohiro ^a   Otsubo, Kazumasa ^b   Oku, Naoto ^a  

^a UNIVERSITY OF SHIZUOKA   (Japan)

^b ASAHI KASEI PHARMA CORPORATION   (Japan)

Author keywords

anti obesity effect; biodistribution; liver; myo inositol; Phosphatidylinositol

Indexed keywords

ANTI-OBESITY EFFECT; ASPARTATE AMINOTRANSFERASE; BIODISTRIBUTION; BIODISTRIBUTIONS; BODY WEIGHT; DIET-INDUCED OBESITY; LIPID METABOLISMS; LIPID SYNTHESIS; MYO-INOSITOL; ORAL ADMINISTRATION; PHOSPHATIDYLINOSITOL; PLASMA LEVELS;

ALCOHOLS; GENE EXPRESSION; GENE EXPRESSION REGULATION; LIVER; METABOLISM; PHYSIOLOGY; RADIATION; RADIOACTIVITY; SUGARS;

NUTRITION;

ANTIOBESITY AGENT; PHOSPHATIDYLINOSITOL;

ANIMAL; ARTICLE; C57BL MOUSE; DRUG EFFECT; GENE EXPRESSION; GENETICS; HUMAN; LIVER; MALE; METABOLISM; MOUSE; OBESITY; TISSUE DISTRIBUTION;

ANIMALS; ANTI-OBESITY AGENTS; GENE EXPRESSION; HUMANS; LIVER; MALE; MICE; MICE, INBRED C57BL; OBESITY; PHOSPHATIDYLINOSITOLS; TISSUE DISTRIBUTION;

MUS;

EID: 78149288277     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/jf102075j     Document Type: Article

References (37)

1. Nagao, K.; Yanagita, T. Bioactive lipids in metabolic syndrome Prog. Lipid Res. 2008, 47 (2) 127-146
2. Cockcroft, S. Phosphatidic acid regulation of phosphatidylinositol 4-phosphate 5-kinases Biochim. Biophys. Acta 2009, 1791 (9) 905-912
3. Holub, B. J. Metabolism and function of myo -inositol and inositol phospholipids Annu. Rev. Nutr. 1986, 6, 563-597
4. Sakisaka, T.; Itoh, T.; Miura, K.; Takenawa, T. Phosphatidylinositol 4,5-bisphosphate phosphatase regulates the rearrangement of actin filaments Mol. Cell. Biol. 1997, 17 (7) 3841-3849
5. Roy, P.; Kalra, N.; Prasad, S.; George, J.; Shukla, Y. Chemopreventive potential of resveratrol in mouse skin tumors through regulation of mitochondrial and PI3K/AKT signaling pathways Pharm. Res. 2009, 26 (1) 211-217
6. Matsunaga, N.; Shimazawa, M.; Otsubo, K.; Hara, H. Phosphatidylinositol inhibits vascular endothelial growth factor-A-Induced migration of human umbilical vein endothelial cells J. Pharmacol. Sci. 2008, 106 (1) 128-135
7. Shirouchi, B.; Nagao, K.; Inoue, N.; Furuya, K.; Koga, S.; Matsumoto, H.; Yanagita, T. Dietary phosphatidylinositol prevents the development of nonalcoholic fatty liver disease in Zucker (fa / fa) rats J. Agric. Food Chem. 2008, 56 (7) 2375-2379
8. Burgess, J. W.; Neville, T. A.; Rouillard, P.; Harder, Z.; Beanlands, D. S.; Sparks, D. L. Phosphatidylinositol increases HDL-C levels in humans J. Lipid Res. 2005, 46 (2) 350-355
9. Wallace, M. A. Effects of Alzheimer's disease-related β amyloid protein fragments on enzymes metabolizing phosphoinositides in brain Biochim. Biophys. Acta 1994, 1227 (3) 183-187
10. Zhang, N. Y.; Kitagawa, K.; Hattori, N.; Nakayama, Y.; Xiong, Z. M.; Wu, B.; Liu, B.; Inagaki, C. Soybean-derived phosphatidylinositol inhibits in vivo low concentrations of amyloid β protein-induced degeneration of hippocampal neurons in V337M human τ-expressing mice Life Sci. 2007, 80 (21) 1971-1976
11. Colodny, L.; Hoffman, R. L. Inositol-Clinical applications for exogenous use Altern. Med. Rev. 1998, 3 (6) 432-447
12. Okazaki, Y.; Katayama, T. Effects of dietary carbohydrate and myo -inositol on metabolic changes in rats fed 1,1,1-trichloro-2,2-bis-(p -chlorophenyl)ethane (DDT) J. Nutr. Biochem. 2003, 14 (2) 81-89
13. Maeba, R.; Hara, H.; Ishikawa, H.; Hayashi, S.; Yoshimura, N.; Kusano, J.; Takeoka, Y.; Yasuda, D.; Okazaki, T.; Kinoshita, M.; Teramoto, T. myo -Inositol treatment increases serum plasmalogens and decreases small dense LDL, particularly in hyperlipidemic subjects with metabolic syndrome J. Nutr. Sci. Vitaminol. 2008, 54 (3) 196-202
14. Palatnik, A.; Frolov, K.; Fux, M.; Benjamin, J. Double-blind, controlled, crossover trial of inositol versus fluvoxamine for the treatment of panic disorder J. Clin. Psychopharmacol. 2001, 21 (3) 335-339
15. Galli, C.; Sirtori, C. R.; Mosconi, C.; Medini, L.; Gianfranceschi, G.; Vaccarino, V.; Scolastico, C. Prolonged retention of doubly labeled phosphatidylcholine in human plasma and erythrocytes after oral administration Lipids 1992, 27 (12) 1005-1012
16. Feig, D. I.; Kang, D. H.; Johnson, R. J. Uric acid and cardiovascular risk N. Engl. J. Med. 2008, 359 (17) 1811-1821
17. Shirouchi, B.; Nagao, K.; Furuya, K.; Inoue, N.; Inafuku, M.; Nasu, M.; Otsubo, K.; Koga, S.; Matsumoto, H.; Yanagita, T. Effect of dietary phosphatidylinositol on cholesterol metabolism in Zucker (fa/fa) rats J. Oleo Sci. 2009, 58 (3) 111-115
18. Zou, C.; Shao, J. Role of adipocytokines in obesity-associated insulin resistance J. Nutr. Biochem. 2008, 19 (5) 277-286
19. Hill, J. W.; Williams, K. W.; Ye, C.; Luo, J.; Balthasar, N.; Coppari, R.; Cowley, M. A.; Cantley, L. C.; Lowell, B. B.; Elmquist, J. K. Acute effects of leptin require PI3K signaling in hypothalamic proopiomelanocortin neurons in mice J. Clin. Invest. 2008, 118 (5) 1796-1805
20. Metlakunta, A. S.; Sahu, M.; Sahu, A. Hypothalamic phosphatidylinositol 3-kinase pathway of leptin signaling is impaired during the development of diet-induced obesity in FVB/N mice Endocrinology 2008, 149 (3) 1121-1128
21. Li, L.; Gronning, L. M.; Anderson, P. O.; Li, S.; Edvardsen, K.; Johnston, J.; Kioussis, D.; Shepherd, P. R.; Wang, P. Insulin induces SOCS-6 expression and its binding to the p85 monomer of phosphoinositide 3-kinase, resulting in improvement in glucose metabolism J. Biol. Chem. 2004, 279 (33) 34107-34114
22. Howard, J. K.; Flier, J. S. Attenuation of leptin and insulin signaling by SOCS proteins Trends Endocrinol. Metab. 2006, 17 (9) 365-371
23. Mooney, R. A.; Senn, J.; Cameron, S.; Inamdar, N.; Boivin, L. M.; Shang, Y.; Furlanetto, R. W. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor. A potential mechanism for cytokine-mediated insulin resistance J. Biol. Chem. 2001, 276 (28) 25889-25893
24. Kernie, S. G.; Liebl, D. J.; Parada, L. F. BDNF regulates eating behavior and locomotor activity in mice EMBO J. 2000, 19 (6) 1290-1300
25. Tsuchida, A.; Nonomura, T.; Nakagawa, T.; Itakura, Y.; Ono-Kishino, M.; Yamanaka, M.; Sugaru, E.; Taiji, M.; Noguchi, H. Brain-derived neurotrophic factor ameliorates lipid metabolism in diabetic mice Diabetes, Obes. Metab. 2002, 4 (4) 262-269 (Pubitemid 34814867)
26. Gray, J.; Yeo, G.; Hung, C.; Keogh, J.; Clayton, P.; Banerjee, K.; McAulay, A.; O'Rahilly, S.; Farooqi, I. S. Functional characterization of human NTRK2 mutations identified in patients with severe early-onset obesity Int. J. Obes. 2007, 31 (2) 359-364
27. Tsao, D.; Thomsen, H. K.; Chou, J.; Stratton, J.; Hagen, M.; Loo, C.; Garcia, C.; Sloane, D. L.; Rosenthal, A.; Lin, J. C. TrkB agonists ameliorate obesity and associated metabolic conditions in mice Endocrinology 2008, 149 (3) 1038-1048
28. Kuroda, A.; Yamasaki, Y.; Matsuhisa, M.; Kubota, M.; Nakahara, I.; Nakatani, Y.; Hoshi, A.; Gorogawa, S.; Umayahara, Y.; Itakura, Y.; Nakagawa, T.; Taiji, M.; Kajimoto, Y.; Hori, M. Brain-derived neurotrophic factor ameliorates hepatic insulin resistance in Zucker fatty rats Metabolism 2003, 52 (2) 203-208
29. Ntambi, J. M.; Miyazaki, M. Regulation of stearoyl-CoA desaturases and role in metabolism Prog. Lipid Res. 2004, 43 (2) 91-104
30. Dobrzyn, A.; Ntambi, J. M. Stearoyl-CoA desaturase as a new drug target for obesity treatment Obes. Rev. 2005, 6 (2) 169-174
31. Jiang, G.; Li, Z.; Liu, F.; Ellsworth, K.; Dallas-Yang, Q.; Wu, M.; Ronan, J.; Esau, C.; Murphy, C.; Szalkowski, D.; Bergeron, R.; Doebber, T.; Zhang, B. B. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase-1 J. Clin. Invest. 2005, 115 (4) 1030-1038
32. Sampath, H.; Miyazaki, M.; Dobrzyn, A.; Ntambi, J. M. Stearoyl-CoA desaturase-1 mediates the pro-lipogenic effects of dietary saturated fat J. Biol. Chem. 2007, 282 (4) 2483-2493
33. Chiba, T.; Han, C. Y.; Vaisar, T.; Shimokado, K.; Kargi, A.; Chen, M. H.; Wang, S.; McDonald, T. O.; O'Brien, K. D.; Heinecke, J. W.; Chait, A. Serum amyloid A3 does not contribute to circulating SAA levels J. Lipid Res. 2009, 50 (7) 1353-1362
34. Marsche, G.; Frank, S.; Raynes, J. G.; Kozarsky, K. F.; Sattler, W.; Malle, E. The lipidation status of acute-phase protein serum amyloid A determines cholesterol mobilization via scavenger receptor class B, type I Biochem. J. 2007, 402 (1) 117-124
35. Scheja, L.; Heese, B.; Zitzer, H.; Michael, M. D.; Siesky, A. M.; Pospisil, H.; Beisiegel, U.; Seedorf, K. Acute-phase serum amyloid A as a marker of insulin resistance in mice Exp. Diabetes Res. 2008, 2008 230837
36. Burgess, J. W.; Boucher, J.; Neville, T. A.; Rouillard, P.; Stamler, C.; Zachariah, S.; Sparks, D. L. Phosphatidylinositol promotes cholesterol transport and excretion J. Lipid Res. 2003, 44 (7) 1355-1363
37. Wassef, N. M.; Alving, C. R. Modulation of phosphatidylinositol turnover by liposomes containing phosphatidylinositol Methods Enzymol. 1987, 141, 244-255